We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
-0.35%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
AUM
$1.59B
AUM Growth
+$469M
Cap. Flow
+$491M
Cap. Flow %
30.91%
Top 10 Hldgs %
26.26%
Holding
2,828
New
215
Increased
1,024
Reduced
629
Closed
413
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPTS icon
101
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
$6.1B
$2.16M 0.14%
74,620
+1,775
+2% +$51.6K
DISV icon
102
Dimensional International Small Cap Value ETF
DISV
$4.98B
$2.16M 0.14%
81,239
+3,528
+5% +$96.8K
UNH icon
103
UnitedHealth
UNH
$376B
$2.09M 0.13%
4,123
+1,949
+90% +$1.11M
QLD icon
104
ProShares Ultra QQQ
QLD
$13.2B
$2.09M 0.13%
38,532
LLY icon
105
Eli Lilly
LLY
$1.02T
$2.06M 0.13%
2,673
+208
+8% +$172K
IBM icon
106
IBM
IBM
$211B
$2.06M 0.13%
9,359
+2,265
+32% +$504K
VHT icon
107
Vanguard Health Care ETF
VHT
$18.1B
$2.04M 0.13%
8,032
-81
-1% -$21.8K
VCLT icon
108
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.81B
$2.03M 0.13%
27,197
+2,282
+9% +$177K
CVX icon
109
Chevron
CVX
$392B
$2.03M 0.13%
14,038
+11,541
+462% +$1.77M
TMO icon
110
Thermo Fisher Scientific
TMO
$213B
$1.99M 0.13%
3,824
+1,368
+56% +$752K
DHR icon
111
Danaher
DHR
$137B
$1.86M 0.12%
8,086
+465
+6% +$114K
ABBV icon
112
AbbVie
ABBV
$443B
$1.8M 0.11%
10,145
+2,675
+36% +$492K
ZTS icon
113
Zoetis
ZTS
$32.4B
$1.78M 0.11%
10,913
+3,611
+49% +$646K
FULT icon
114
Fulton Financial
FULT
$4.66B
$1.76M 0.11%
91,464
+523
+0.6% +$10.2K
DIS icon
115
Walt Disney
DIS
$167B
$1.75M 0.11%
15,718
+9,678
+160% +$1.02M
ASML icon
116
ASML
ASML
$626B
$1.74M 0.11%
2,506
+1,497
+148% +$1.08M
CRM icon
117
Salesforce
CRM
$151B
$1.71M 0.11%
5,123
+4,149
+426% +$1.32M
VTIP icon
118
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
$1.69M 0.11%
+34,951
New +$1.71M
FSTA icon
119
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.41B
$1.68M 0.11%
+33,894
New +$1.72M
ISRG icon
120
Intuitive Surgical
ISRG
$125B
$1.67M 0.11%
3,208
+432
+16% +$225K
XDSQ icon
121
Innovator US Equity Accelerated ETF Quarterly
XDSQ
$71.1M
$1.67M 0.1%
45,748
-1,285
-3% -$46.4K
IWF icon
122
iShares Russell 1000 Growth ETF
IWF
$124B
$1.64M 0.1%
16,340
+116
+0.7% +$11.4K
TDG icon
123
TransDigm Group
TDG
$70.2B
$1.6M 0.1%
1,260
+23
+2% +$30.3K
FISV
124
Fiserv Inc
FISV
$28.8B
$1.6M 0.1%
7,773
-497
-6% -$101K
MCO icon
125
Moody's
MCO
$82.8B
$1.59M 0.1%
3,363
+5
+0.1% +$2.39K

Similar funds

Arax Advisory Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Arax Advisory Partners held 2,828 positions worth $1.59B, up 42% from $1.12B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Arax Advisory Partners deployed $491M of net new capital in Q4 2024, opening 215 new positions and adding to 1,024 existing holdings. Its largest new stake was First Trust Low Duration Strategic Focus ETF: 643,026 shares worth $12.1M.

By sector, the portfolio is most concentrated in Technology at 5.9% of assets, up from 5.6% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Morningstar Mid-Cap Value ETF, an estimated $3.07M trimmed.

  • Arax Advisory Partners's largest Q4 2024 buy was First Trust Low Duration Strategic Focus ETF: 643,026 shares worth $12.1M.
  • Arax Advisory Partners added most to Vanguard Morningstar Growth ETF in Q4 2024, an estimated $33.3M increase.
  • Arax Advisory Partners's biggest Q4 2024 reduction was Vanguard Morningstar Mid-Cap Value ETF, cutting an estimated $3.07M.
  • Arax Advisory Partners fully exited WillScot Mobile Mini Holdings in Q4 2024, selling an estimated $508K.
  • Arax Advisory Partners's ten largest holdings make up 26% of its $1.59B portfolio in Q4 2024.
  • Arax Advisory Partners opened 215 new positions and closed 413 in Q4 2024.
  • Arax Advisory Partners's portfolio value rose 42% quarter-over-quarter to $1.59B.

Based on Arax Advisory Partners's 13F filing for Q4 2024, filed 5 Feb 2025.